Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


The Angels Initiative

Stroke prevention


  Kidney Transplantation

  Free Subscription


Articles published in Br J Clin Pharmacol

Retrieve available abstracts of 10 articles:
HTML format



Single Articles


    May 2022
  1. ZHOU Y, Li Y, Xie X, Song L, et al
    Higher Incidence of Neurotoxicity and Skin Hyperpigmentation in Renal Transplant Patients Treated With Polymyxin B.
    Br J Clin Pharmacol. 2022 May 4. doi: 10.1111/bcp.15384.
    PubMed     Abstract available


    January 2022
  2. LE TILLY O, Gatault P, Baron C, Bejan-Angoulvant T, et al
    Is CD25 blockade optimal in kidney transplant patients treated with basiliximab? A target-mediated drug disposition (TMDD) model.
    Br J Clin Pharmacol. 2022 Jan 18. doi: 10.1111/bcp.15235.
    PubMed     Abstract available


    December 2021
  3. DESTERE A, Gandonniere CS, Asberg A, Loustaud-Ratti V, et al
    A single Bayesian estimator for iohexol clearance estimation in ICU, liver failure and renal transplant patients.
    Br J Clin Pharmacol. 2021 Dec 23. doi: 10.1111/bcp.15197.
    PubMed     Abstract available


    October 2021
  4. SOMMERER C, Brunet M, Budde K, Millan O, et al
    Monitoring of gene expression in tacrolimus-treated de novo renal allograft recipients facilitates individualized immunosuppression: Results of the IMAGEN study.
    Br J Clin Pharmacol. 2021;87:3851-3862.
    PubMed     Abstract available


    April 2021
  5. YIN S, Wang X, Huang Z, Fan Y, et al
    Tacrolimus Variability Score Outperforms Coefficient of Variation in Predicting Clinical Outcomes of Living Kidney Transplantation.
    Br J Clin Pharmacol. 2021 Apr 25. doi: 10.1111/bcp.14876.
    PubMed     Abstract available


  6. RONG Y, Jun H, Kiang TKL
    Population pharmacokinetics of mycophenolic acid in paediatric patients.
    Br J Clin Pharmacol. 2021;87:1730-1757.
    PubMed     Abstract available


    March 2021
  7. SALLUSTIO BC, Noll BD, Hu R, Barratt DT, et al
    Tacrolimus dose, blood concentrations and acute nephrotoxicity, but not CYP3A5/ABCB1 genetics, are associated with allograft tacrolimus concentrations in renal transplant recipients.
    Br J Clin Pharmacol. 2021 Mar 1. doi: 10.1111/bcp.14806.
    PubMed     Abstract available


    December 2020
  8. JONES TE
    Problems with paper entitled The impact of tacrolimus exposure on extrarenal adverse effects in adult transplant recipients.
    Br J Clin Pharmacol. 2020;86:2536-2537.
    PubMed    


  9. ROBERTSEN I, Woillard JB, Asberg A
    Why dose adjust systemic exposure when looking for associations with adverse events in tacrolimus-treated transplant recipients?
    Br J Clin Pharmacol. 2020;86:2535.
    PubMed    


    October 2020
  10. FRANCKE MI, Hesselink DA, Li Y, Koch BCP, et al
    Monitoring the Tacrolimus Concentration in peripheral bLood mononuclear cells of Kidney Transplant Recipients.
    Br J Clin Pharmacol. 2020 Oct 6. doi: 10.1111/bcp.14585.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Kidney Transplantation is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: